Literature DB >> 24450150

[Differential expression of genes that encode glycolysis enzymes in kidney and lung cancer in humans].

N Yu Oparina, A V Snezhkina, A F Sadritdinova, V A Veselovskii, A A Dmitriev, V N Senchenko, N V Mel'nikova, A S Speranskaya, M V Darii, O A Stepanov, I M Barkhatov, A V Kudryavtseva.   

Abstract

Glycolysis is a main catabolic pathway of glucose metabolism, accompanied by ATP synthesis. More than 30 enzymes are involved in glycolysis, and genes that encode them can be considered housekeeping genes due to the high conservatism and evolutionary antiquity of the process. We studied the expression of these genes in kidney papillary cancer and planocellular lung cancer via the bioinformatic analysis of transcriptome database and method of quantitative real time PCR. Quantitative analysis of mRNA level demonstrated that only a part ofgenes that encode glycolysis enzymes maintain relatively stable mRNA level, including the HK1, ADPGK, GPI, PGK1, and PKM2 genes in kidney papillary cancer and the ADPGK, ALDOA, GAPDH, PGK1, BPGM, ENO1, and PKM2 genes in planocellular lung cancer. The frequent increase in the mRNA expression of PFKP, ALDOA, and GAPDH genes in kidney cancer, as well as the GPI gene in lung cancer, were detected for the first time by real time PCR. For other genes, their differential expression was demonstrated; the cases of both a decrease and increase in the mRNA level were detected. Thus, several genes that can be used as control genes in transcriptome analysis by real time PCR in kidney and lung cancer, as well as a number of differentially expressed genes that can be potential oncomarkers, were identified.

Entities:  

Mesh:

Year:  2013        PMID: 24450150     DOI: 10.7868/s0016675813050111

Source DB:  PubMed          Journal:  Genetika        ISSN: 0016-6758


  16 in total

1.  Effect of lentivirus-mediated shRNA inactivation of HK1, HK2, and HK3 genes in colorectal cancer and melanoma cells.

Authors:  Anna V Kudryavtseva; Maria S Fedorova; Alex Zhavoronkov; Alexey A Moskalev; Alexander S Zasedatelev; Alexey A Dmitriev; Asiya F Sadritdinova; Irina Y Karpova; Kirill M Nyushko; Dmitry V Kalinin; Nadezhda N Volchenko; Nataliya V Melnikova; Kseniya M Klimina; Dmitry V Sidorov; Anatoly Y Popov; Tatiana V Nasedkina; Andrey D Kaprin; Boris Y Alekseev; George S Krasnov; Anastasiya V Snezhkina
Journal:  BMC Genet       Date:  2016-12-22       Impact factor: 2.797

2.  Overexpression of Hexokinase 1 as a poor prognosticator in human colorectal cancer.

Authors:  Xiaosheng He; Xutao Lin; Muyan Cai; Xiaobin Zheng; Lei Lian; Dejun Fan; Xiaojian Wu; Ping Lan; Jianping Wang
Journal:  Tumour Biol       Date:  2015-10-17

3.  Mutational load in carotid body tumor.

Authors:  Anna V Kudryavtseva; Elena N Lukyanova; Dmitry V Kalinin; Andrew R Zaretsky; Anatoly V Pokrovsky; Alexander L Golovyuk; Maria S Fedorova; Elena A Pudova; Sergey L Kharitonov; Vladislav S Pavlov; Anastasiya A Kobelyatskaya; Nataliya V Melnikova; Alexey A Dmitriev; Andrey P Polyakov; Boris Y Alekseev; Marina V Kiseleva; Andrey D Kaprin; George S Krasnov; Anastasiya V Snezhkina
Journal:  BMC Med Genomics       Date:  2019-03-13       Impact factor: 3.063

4.  Definition of a Novel Feed-Forward Mechanism for Glycolysis-HIF1α Signaling in Hypoxic Tumors Highlights Aldolase A as a Therapeutic Target.

Authors:  Geoffrey Grandjean; Petrus R de Jong; Brian James; Mei Yee Koh; Robert Lemos; John Kingston; Alexander Aleshin; Laurie A Bankston; Claudia P Miller; Eun Jeong Cho; Ramakrishna Edupuganti; Ashwini Devkota; Gabriel Stancu; Robert C Liddington; Kevin Dalby; Garth Powis
Journal:  Cancer Res       Date:  2016-06-03       Impact factor: 12.701

5.  MicroRNA-513a-3p regulates colorectal cancer cell metabolism via targeting hexokinase 2.

Authors:  Chen Li; Zhijin Yu; Jinpeng Ye
Journal:  Exp Ther Med       Date:  2020-05-07       Impact factor: 2.447

6.  Comparative transcriptome analysis of papilla and skin in the sea cucumber, Apostichopus japonicus.

Authors:  Xiaoxu Zhou; Jun Cui; Shikai Liu; Derong Kong; He Sun; Chenlei Gu; Hongdi Wang; Xuemei Qiu; Yaqing Chang; Zhanjiang Liu; Xiuli Wang
Journal:  PeerJ       Date:  2016-03-07       Impact factor: 2.984

7.  Upregulation of NETO2 gene in colorectal cancer.

Authors:  Maria S Fedorova; Anastasiya V Snezhkina; Elena A Pudova; Ivan S Abramov; Anastasiya V Lipatova; Sergey L Kharitonov; Asiya F Sadritdinova; Kirill M Nyushko; Kseniya M Klimina; Mikhail M Belyakov; Elena N Slavnova; Nataliya V Melnikova; Maria A Chernichenko; Dmitry V Sidorov; Marina V Kiseleva; Andrey D Kaprin; Boris Y Alekseev; Alexey A Dmitriev; Anna V Kudryavtseva
Journal:  BMC Genet       Date:  2017-12-28       Impact factor: 2.797

8.  High expression of Aldolase A predicts poor survival in patients with clear-cell renal cell carcinoma.

Authors:  Ning Na; Heng Li; Chengfang Xu; Bin Miao; Liangqing Hong; Zhengyu Huang; Qiu Jiang
Journal:  Ther Clin Risk Manag       Date:  2017-02-27       Impact factor: 2.423

9.  Dysfunctional miRNA-Mediated Regulation in Chromophobe Renal Cell Carcinoma.

Authors:  Xiaohan Sun; Junying Zhang
Journal:  PLoS One       Date:  2016-06-03       Impact factor: 3.240

10.  Hexokinase 3 dysfunction promotes tumorigenesis and immune escape by upregulating monocyte/macrophage infiltration into the clear cell renal cell carcinoma microenvironment.

Authors:  Wenhao Xu; Wang-Rui Liu; Yue Xu; Xi Tian; Aihetaimujiang Anwaier; Jia-Qi Su; Wen-Kai Zhu; Guo-Hai Shi; Gao-Meng Wei; Yong-Ping Huang; Yuan-Yuan Qu; Hai-Liang Zhang; Ding-Wei Ye
Journal:  Int J Biol Sci       Date:  2021-06-01       Impact factor: 6.580

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.